WO2002024210A3 - Halogen compounds for use in medicine - Google Patents

Halogen compounds for use in medicine Download PDF

Info

Publication number
WO2002024210A3
WO2002024210A3 PCT/GB2001/004164 GB0104164W WO0224210A3 WO 2002024210 A3 WO2002024210 A3 WO 2002024210A3 GB 0104164 W GB0104164 W GB 0104164W WO 0224210 A3 WO0224210 A3 WO 0224210A3
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
halogen compounds
compound
halogen
active pharmaceutical
Prior art date
Application number
PCT/GB2001/004164
Other languages
French (fr)
Other versions
WO2002024210A2 (en
Inventor
Robert Edward Chapman
Robert Peter Chapman
Original Assignee
Robert Edward Chapman
Robert Peter Chapman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Edward Chapman, Robert Peter Chapman filed Critical Robert Edward Chapman
Priority to AU2001287884A priority Critical patent/AU2001287884A1/en
Priority to EP01967509A priority patent/EP1408993A2/en
Publication of WO2002024210A2 publication Critical patent/WO2002024210A2/en
Publication of WO2002024210A3 publication Critical patent/WO2002024210A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A compound for use as an active pharmaceutical substance comprising a halogen compound.
PCT/GB2001/004164 2000-09-19 2001-09-19 Halogen compounds for use in medicine WO2002024210A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001287884A AU2001287884A1 (en) 2000-09-19 2001-09-19 Halogen compounds for use in medicine
EP01967509A EP1408993A2 (en) 2000-09-19 2001-09-19 Halogen compounds for use in medicine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0022922.9 2000-09-19
GBGB0022922.9A GB0022922D0 (en) 2000-09-19 2000-09-19 Compounds for use in medicine

Publications (2)

Publication Number Publication Date
WO2002024210A2 WO2002024210A2 (en) 2002-03-28
WO2002024210A3 true WO2002024210A3 (en) 2002-08-22

Family

ID=9899702

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/004164 WO2002024210A2 (en) 2000-09-19 2001-09-19 Halogen compounds for use in medicine

Country Status (4)

Country Link
EP (1) EP1408993A2 (en)
AU (1) AU2001287884A1 (en)
GB (1) GB0022922D0 (en)
WO (1) WO2002024210A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062355A2 (en) * 2001-02-07 2002-08-15 Rainburst, Llc Hydriodic acid and iodide salts for treatment of male impotence
DE10343047B4 (en) * 2003-09-16 2008-08-07 Zfb Project-Management Gmbh Organic material antioxidant and method of treating same
MX2016010328A (en) * 2014-02-10 2017-02-06 Hutchinson Fred Cancer Res Halogen treatment of heart attack and ischemic injury.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB364394A (en) * 1930-05-10 1932-01-07 Siegwart Hermann Process for the preparation of organic derivatives of bromine
EP0021424A1 (en) * 1979-06-26 1981-01-07 Kanoldt Arzneimittel GmbH Iodide containing composition for treating ocular opacity
DE3643001A1 (en) * 1986-12-17 1988-06-23 Daniel Albert Dubrulle Pharmaceutical composition
US4990510A (en) * 1986-01-21 1991-02-05 Leif Lundblad Substituted indoloquinoxalines
EP0528697A1 (en) * 1991-08-21 1993-02-24 Diversey Corporation Sporicidal disinfectant compositions production and use thereof
WO1996032952A1 (en) * 1995-04-21 1996-10-24 Oswald Edmonds Hooper Caffeine composition as medicament and use thereof
WO1999002145A1 (en) * 1997-07-07 1999-01-21 Cambridge Neuroscience, Inc. Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB364394A (en) * 1930-05-10 1932-01-07 Siegwart Hermann Process for the preparation of organic derivatives of bromine
EP0021424A1 (en) * 1979-06-26 1981-01-07 Kanoldt Arzneimittel GmbH Iodide containing composition for treating ocular opacity
US4990510A (en) * 1986-01-21 1991-02-05 Leif Lundblad Substituted indoloquinoxalines
DE3643001A1 (en) * 1986-12-17 1988-06-23 Daniel Albert Dubrulle Pharmaceutical composition
EP0528697A1 (en) * 1991-08-21 1993-02-24 Diversey Corporation Sporicidal disinfectant compositions production and use thereof
WO1996032952A1 (en) * 1995-04-21 1996-10-24 Oswald Edmonds Hooper Caffeine composition as medicament and use thereof
WO1999002145A1 (en) * 1997-07-07 1999-01-21 Cambridge Neuroscience, Inc. Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARTY I S ET AL: "Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 35, no. 4, April 2000 (2000-04-01), pages 449 - 457, XP004330428, ISSN: 0223-5234 *

Also Published As

Publication number Publication date
EP1408993A2 (en) 2004-04-21
AU2001287884A1 (en) 2002-04-02
GB0022922D0 (en) 2000-11-01
WO2002024210A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
MXPA03006884A (en) Pharmaceutical formulation.
AU1071301A (en) Pharmaceutical compounds
AU2001273376A1 (en) Drug delivery device for animals
MXPA03007641A (en) Pharmaceutical formulation.
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2002214006A1 (en) Drugs for diabetes
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2001258550A1 (en) Insulin formulation for inhalation
ZA200304928B (en) Medicament containing a polyamine as an active substance.
AU5722900A (en) Pharmaceutical compounds
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
WO2002024210A3 (en) Halogen compounds for use in medicine
AU2001248943A1 (en) Pharmaceutical curative compound
ZA200203311B (en) Pharmaceutical carrier formulation.
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU2002218159A1 (en) Transparent active substance capsules
AU2001292578A1 (en) Pharmaceutical compounds
AU2001233706A1 (en) Container for medicaments
HK1046133A1 (en) Pharmaceutical compounds.
EP1199076A3 (en) Medicament containing tocotrienol as active component

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001967509

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001967509

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP